New study tracks organ health after sickle cell 'Cures'

NCT ID NCT05153967

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This study follows 750 people with sickle cell disease to see how curative therapies affect the heart, lungs, and kidneys over time. Researchers will compare those who received a stem cell transplant with those on standard treatment. The goal is to understand whether curative therapies improve or worsen organ damage, helping patients make better treatment choices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors and patients decide whether curative therapy or standard care is better for long-term heart, lung, and kidney health.
What could go wrong
This is an observational study, not a treatment trial. It will not test a new drug or cure, and results may take years to influence care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's National Medical Center

    NOT_YET_RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Emory University School of Medicine

    NOT_YET_RECRUITING

    Atlanta, Georgia, 30322, United States

  • Johns Hopkins Hospital

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21287, United States

  • National Institutes of Health Clinical Center

    NOT_YET_RECRUITING

    Bethesda, Maryland, 20814, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232-9000, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.